Sign In   Register

Cannabis and Hemp Industry Investment News

Cannabis Industry Press Releases and News Articles from the best investment journalist in the industry. Stay updated on all cannabis investment news from every online source, on MjInvest.com

Lexaria Bioscience inks CBD beverage license agreement in US with Nic's Beverages

Nic's Beverages CEO John Goodpasture says DehydraTECH technology is 'perfect' for allowing the delivery of CBD from hemp oil with 'zero impact' on the...

Buds & Duds: Cannabis stocks continue to slump but Lexaria Bioscience shares shine on CBD beverage deal

Lexaria's DehydraTECH technology can be applied to foods, beverages, oral suspensions, tablets and capsules Cannabis stocks were faced with yet anothe...

Lexaria Bioscience springs for digital marketing services from the Richmond Club

What are you searching for? viewLexaria Bioscience Corp. The company will help Lexaria with investor presentations, articles and videos, and other dig...

Lexaria Bioscience shareholders approve the appointment of four directors

What are you searching for? viewLexaria Bioscience Corp. Shareholders approved all matters at the annual general meeting, including the appointment of...

Lexaria Bioscience formulates enhanced DehydraTECH for more efficient cannabis delivery

What are you searching for? viewLexaria Bioscience Corp. () (OTCMKTS:LXRP) CEO Chris Bunka tells Proactive Investors a new version of the Kelowna, Bri...

Lexaria Bioscience crafts new DehydraTECH innovation, files patents

New enhanced DehydraTECH formulation delivers 8X more CBD into blood and over 19X more CBD into brain tissue than standard formulations The Kelowna, B...

Lexaria’s DehydraTECH combined with nanotech techniques delivers more CBD into brain tissue by over tenfold

The Canadian company has developed the science to combine DehydraTECH with nanoemulsification for specific performance applications The Kelowna, Briti...

Lexaria Bioscience, Nuka Enterprises expand relationship to rapidly grow market for Nuka’s 1906 edibles brand

Over the next two years, 1906 is expanding its premium edibles, which combine cannabis and plant medicines, to key legal markets including Illinois, O...

Lexaria’s DehydraTECH formulation delivers over tenfold CBD to bloodstream than conventional industry formulations

The company’s formulation delivered 475% more CBD to the bloodstream in 15 minutes than other standard industry formulations The Kelowna-headquartered...

Lexaria Bioscience inks US partnership to produce CBD beverages

What are you searching for? viewLexaria Bioscience Corp. The company is pairing its DehydraTECH system with a Nevada-based private company The Kelowna...

Lexaria Bioscience welcomes four new experts to advisory board to guide ongoing research

The Kelowna-headquartered company has developed and out-licenses its disruptive DehydraTECH technology Lexaria has expanded its advisory board () (OTC...

Lexaria Bioscience Corp announces beverage license deal with California cannabis company

The company said the five-year definitive agreement will provide its Dehydratech technology to a private California-based cannabis company for use in ...

Lexaria Bioscience renews CEO Chris Bunka and President John Docherty's contracts

What are you searching for? viewLexaria Bioscience Corp. The new contracts last for three years and will allow the company to make sure its senior tea...

Lexaria Bioscience gains after announcing cannabinoid R&D project is underway

This project is testing for a variety of potential performance-enhancing variations of the company's DehydraTECH delivery technology DehydraTECH can b...

Lexaria Bioscience cites FDA statement on nicotine replacement therapy to help smokers quit

FDA Commissioner Scott Gottlieb said nicotine replacement therapy is 'generally considered to double the likelihood of a successful quit attempt' The ...

Lexaria Bioscience sees positive results from study using DehydraTECH Technology

What are you searching for? viewLexaria Bioscience Corp. Lexaria Bioscience (CSE:LXX-OTCQX:LXRP) President John Docherty joined Steve Darling from Pro...

Lexaria Bioscience announces optimistic new trial results for its hemp oil capsule TurboCBD

A single 90mg dose of TurboCBD showed evidence of lower blood pressure and higher blood flow to the brain Lexaria intends to conduct further clinical ...

Lexaria Bioscience announces partnership with U.S. giant Altria to fund R&D

What are you searching for? viewLexaria Bioscience Corp. Lexaria Bioscience (CSE:LXX-OTCQX:LXRP) CEO Chris Bunka joined Steve Darling from Proactive I...

Lexaria Bioscience inks deal with Altria Ventures to develop reduced-risk nicotine products; shares soar

Shares of Lexaria jumped after the announcement, which will fund research on oral forms of nicotine delivery, using Lexaria's DehydraTECH technology A...

Lexaria Bioscience seeks Health Canada application for cannabinoid research lab in British Columbia

What are you searching for? viewLexaria Bioscience Corp. Separately, the company has appointed Dr Ed Ergenzinger as chief legal officer and senior vic...


MjInvest.com